J&J Beats Earnings and Guides Higher

Finally some good news from Johnson & Johnson ($JNJ). This company has made just about every mistake possible over the last year but at least they’re still making a good profit.

For the first quarter, JNJ earned $1.35 per share (after charges) which beat Wall Street’s estimate by nine cents per share.

But more importantly, JNJ raised its full-year EPS guidance. The earlier guidance was $4.80 to $4.90. Now it’s $4.90 to $5.00. That’s excellent news. In January, the company gave the initial guidance numbers which disappointed Wall Street. Today’s news should help restore some faith in JNJ.

The stock is currently up about 3% today. Also, here’s more on the impact a Synthes deal could have on the medical device industry.

Posted by on April 19th, 2011 at 12:00 pm


The information in this blog post represents my own opinions and does not contain a recommendation for any particular security or investment. I or my affiliates may hold positions or other interests in securities mentioned in the Blog, please see my Disclaimer page for my full disclaimer.